Small Molecule Inhibitors Targeting the “Undruggable” Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective

Q Cui, C Huang, JY Liu, JT Zhang - Journal of Medicinal …, 2023 - ACS Publications
Survivin, a homodimeric protein and a member of the IAP family, plays a vital function in cell
survival and cycle progression by interacting with various proteins and complexes. Its …

A review: Biological activities of novel cyanopyridine derivatives

Y Wu, T Wu, Y Huang - Archiv der Pharmazie, 2023 - Wiley Online Library
The discovery of new therapeutic drugs is heavily reliant on the structural diversity and
pharmacological properties of heterocyclic compounds. Pyridine heterocyclic‐related …

Nicotinonitrile-derived apoptotic inducers: Design, synthesis, X-ray crystal structure and Pim kinase inhibition

SM Aboukhatwa, AO Ibrahim, H Aoyama… - Bioorganic …, 2022 - Elsevier
Although a plethora of targeted anticancer small molecule drugs became available, the low
response rate and drug resistance imply the continuous need for expanding the anticancer …

Synthesis, molecular modeling Insights, and anticancer assessment of novel polyfunctionalized Pyridine congeners

MG Abouelenein, AA El-Rashedy, HM Awad… - Bioorganic …, 2023 - Elsevier
The present study describes synthesizing a novel series of polyfunctionalized pyridine
congeners 1–18 and assessed for cytotoxic efficacies versus HCT-116, MCF-7, and HepG-2 …

Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl) benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity

MA Shaldam, AF Khalil, H Almahli… - Archiv der …, 2024 - Wiley Online Library
Abstract New 5‐cyano‐6‐oxo‐pyridine‐based sulfonamides (6a–m and 8a–d) were
designed and synthesized to potentially inhibit both the epidermal growth factor receptor …

New pyridine and chromene scaffolds as potent vasorelaxant and anticancer agents

DH Dawood, AM Srour, DO Saleh, KJ Huff, F Greco… - Rsc Advances, 2021 - pubs.rsc.org
Based on studies that have reported the association between cancer and cardiovascular
diseases, new series of pyridine-(3a–o) and/or chromene-(4a–e) carbonitrile analogous …

Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells

X Wang, X Xuetao, M Wu, P Wu, Z Sheng… - Journal of Enzyme …, 2022 - Taylor & Francis
Roburic acid (ROB) is a naturally occurred tetracyclic triterpenoid, and the anticancer activity
of this compound has not been reported. Docetaxel (DOC) is the first-line chemotherapeutic …

3-Cyano-2-oxa-pyridines: a promising template for diverse pharmacological activities

AK Bass, E Abdelhafez, M El-Zoghbi… - Journal of advanced …, 2021 - journals.ekb.eg
Pyridines have occupied a unique place in medicinal chemistry as it is widely profound as
natural products and formed the integral backbone of great number of drugs in the market. In …

[PDF][PDF] Synthesis and characterization of some new pyridine and pyrimidine derivatives and studying their biological activities

IRA Al-Hussein, ZAM Al-Shuhaib - Baghdad Science Journal, 2023 - iasj.net
Heterocyclic systems, which are essential in medicinal chemistry due to their promising
cytotoxic activity, are one of the most important families of organic molecules found in nature …

Design, synthesis and biological evaluation of cyanopyridines, pyridopyrazolopyrimidines and pyridopyrazolotriazines as potential anticancer agents

RM Keshk, BM Izzularab - Current Organic Synthesis, 2021 - ingentaconnect.com
Background: The continuous need for new anticancer drugs is never-ending task due to
cancer resistance to the existing drugs. Objective: This article aimed to design, synthesis …